{"source_url": "https://www.fiercepharma.com", "url": "https://www.fiercepharma.com/pharma/regeneron-a-national-strategic-asset-for-its-quick-response-to-covid-19-outbreak-analyst?utm_source=internal&utm_medium=rss", "title": "Regeneron a 'national strategic asset' for quick response to COVID-19 outbreak: analyst", "top_image": "https://qtxasset.com/fiercepharma/1584109361/regn.jpg/regn.jpg?s_XYyYFo0dRn21.batDdqFbzmVljpEHT", "meta_img": "https://qtxasset.com/fiercepharma/1584109361/regn.jpg/regn.jpg?s_XYyYFo0dRn21.batDdqFbzmVljpEHT", "images": ["https://www.fiercepharma.com/themes/custom/tektite/assets/images/footer-questex.svg", "https://www.fiercepharma.com/themes/custom/tektite/assets/images/logo-questex.svg", "https://qtxasset.com/styles/content_well_thumb/s3/fiercepharma/1584112052/Bavencio.jpg/Bavencio.jpg?d4as54R02dxuL2rVXWznDlPkLVizG3Nk&itok=zw4Vz5iG", "https://qtxasset.com/styles/content_well_thumb/s3/fiercepharma/1584108999/airline.jpg/airline.jpg?OMorDVJTGc0L7Va._DeP7aiCt4e1YfIV&itok=8A9hY7CE", "https://www.fiercepharma.com/s3/files/styles/breakpoint_sm_default_480px_w/s3/fiercepharma/1584109361/regn.jpg/regn.jpg?itok=k_61iw7q", "https://qtxasset.com/styles/content_well_thumb/s3/fiercepharma/1584112784/shutterstock_157699853.jpg/shutterstock_157699853.jpg?klb5Hbn8u7niH1y2rAmpamkHQDECs3V3&itok=GlF2XEhM", "https://qtxasset.com/fiercepharma/1584109361/regn.jpg/regn.jpg?s_XYyYFo0dRn21.batDdqFbzmVljpEHT", "https://www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/logo-pharma.svg?v=1.01"], "movies": [], "text": "Drugmakers of all shapes and sizes are chasing after therapeutics and vaccines to fight the novel coronavirus. But among the pack, one company's track record might give it the jump on a treatment\u2014and at least one analyst is not afraid to heap praise on its efforts.\n\nRegeneron's \"innovative horsepower and initiative\" in its response to COVID-19, including a push to repurpose arthritis med Kevzara and quickly identify new antibodies to target the virus, has put the drugmaker in the lead to develop a treatment, Evercore ISI analyst Josh Schimmer said in a note to investors Friday.\n\nAfter a luncheon with CEO Len Schleifer, Schimmer touted Regeneron's response not only to COVID-19 but also Ebola as a \"national strategic asset\" for the U.S. given the drugmaker's quick mobilization in outbreaks.\n\nWebinar Use Serialization Data to Maximize Performance and Minimize Risks Wednesday, March 18 | 11am ET / 8am PT\n\n\n\nSerialized products generate a wealth of data as they move through the supply chain. What if you could access and analyze this data to gain operational visibility and powerful business insight? It\u2019s time to put your serialization investment to work for you. Register Now\n\n\"Our most important takeaway is that the COVID pandemic is a lesson of how lucky the country is to have (Regeneron)\u2013\u2013it is poised to perhaps have the biggest impact on this outbreak,\" Schimmer wrote.\n\nRELATED: Could arthritis med Kevzara hold promise against the novel coronavirus? Sanofi, Regeneron aim to find out", "keywords": [], "meta_keywords": ["Regeneron Pharmaceuticals", "Eylea", "coronavirus", "COVID-19"], "tags": ["COVID-19", "coronavirus"], "authors": ["Kyle Blankenship"], "publish_date": null, "summary": "", "article_html": "", "meta_description": "Drugmakers of all shapes and sizes are chasing after therapeutics and vaccines to fight the novel coronavirus.\u00a0But among the pack, one\u00a0company's track record might give it the jump on a treatment\u2014and\u00a0at least one\u00a0analyst is not afraid to lavish praise.", "meta_lang": "en", "meta_favicon": "/themes/custom/tektite_fierce/favicon.ico", "meta_data": {"og": {"site_name": "FiercePharma", "url": "https://www.fiercepharma.com/pharma/regeneron-a-national-strategic-asset-for-its-quick-response-to-covid-19-outbreak-analyst", "title": "Regeneron a 'national strategic asset' for quick response to COVID-19 outbreak: analyst", "description": "Drugmakers of all shapes and sizes are chasing after therapeutics and vaccines to fight the novel coronavirus.\u00a0But among the pack, one\u00a0company's track record might give it the jump on a treatment\u2014and\u00a0at least one\u00a0analyst is not afraid to lavish praise.", "image": {"identifier": "https://qtxasset.com/fiercepharma/1584109361/regn.jpg/regn.jpg?s_XYyYFo0dRn21.batDdqFbzmVljpEHT", "secure_url": "https://qtxasset.com/fiercepharma/1584109361/regn.jpg/regn.jpg?s_XYyYFo0dRn21.batDdqFbzmVljpEHT"}}, "twitter": {"card": "summary_large_image", "description": "Drugmakers of all shapes and sizes are chasing after therapeutics and vaccines to fight the novel coronavirus.\u00a0But among the pack, one\u00a0company's track record might give it the jump on a treatment\u2014and\u00a0at least one\u00a0analyst is not afraid to lavish praise.", "title": "Regeneron a 'national strategic asset' for quick response to COVID-19 outbreak: analyst", "url": "https://www.fiercepharma.com/pharma/regeneron-a-national-strategic-asset-for-its-quick-response-to-covid-19-outbreak-analyst", "image": "https://qtxasset.com/fiercepharma/1584109361/regn.jpg/regn.jpg?s_XYyYFo0dRn21.batDdqFbzmVljpEHT"}, "news_keywords": "Regeneron Pharmaceuticals, Eylea,coronavirus, COVID-19", "description": "Drugmakers of all shapes and sizes are chasing after therapeutics and vaccines to fight the novel coronavirus.\u00a0But among the pack, one\u00a0company's track record might give it the jump on a treatment\u2014and\u00a0at least one\u00a0analyst is not afraid to lavish praise.", "keywords": "Regeneron Pharmaceuticals, Eylea,coronavirus, COVID-19", "article": {"tag": "COVID-19"}, "gtm-keywords": "Regeneron Pharmaceuticals, Eylea", "gtm-article": 458706, "parsely-tags": "COVID-19", "gtm-topics": "coronavirus, COVID-19", "parsely-section": "Pharma", "parsely-title": "Regeneron a 'national strategic asset' for quick response to COVID-19 outbreak: analyst", "gtm-contenttype": "Article", "gtm-section": "Pharma", "parsely-post-id": 458706, "parsely-author": "Kyle Blankenship", "parsely-image-url": "https://qtxasset.com/fiercepharma/1584109361/regn.jpg/regn.jpg?s_XYyYFo0dRn21.batDdqFbzmVljpEHT", "parsely-type": "post", "parsely-pub-date": "2020-03-13T11:50:00-0400", "parsely-link": "https://www.fiercepharma.com/pharma/regeneron-a-national-strategic-asset-for-its-quick-response-to-covid-19-outbreak-analyst", "Generator": "Drupal 8 (https://www.drupal.org)", "MobileOptimized": "width", "HandheldFriendly": "true", "viewport": "width=device-width, initial-scale=1.0", "msapplication-TileColor": "#da532c", "msapplication-TileImage": "/themes/custom/tektite_fierce/mstile-144x144.png?v=wAAmkK2yLl", "theme-color": "#ffffff"}, "canonical_link": "https://www.fiercepharma.com/pharma/regeneron-a-national-strategic-asset-for-its-quick-response-to-covid-19-outbreak-analyst"}